ONCOLOGIC OUTCOMES OF INTRAVESICAL THERAPY IN THE MANAGEMENT OF NON-MUSCLE INVASIVE BLADDER CANCER WITH VARIANT HISTOLOGY

被引：0
|
作者：
Zaeem, Lone
Andrew, Wood
Rebecca, Campbell
Georges-Pascal, Haber
Mohamed, Eltemamy
Samuel, Haywood C.
Christopher, Weight J.
Nima, Almassi
Reza, Alaghehbandan
Li Jianbo
Byron, Lee H.
机构：
[1] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA
[2] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA
[3] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44106 USA
[4] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA
[5] MD Anderson Canc Ctr, Dept Urol, Houston, TX USA
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2024年 / 42卷
关键词：
D O I：
10.1016/j.urolonc.2024.01.202
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
165
引用
收藏
页码：S71 / S71
页数：1
相关论文
共 50 条
  • [21] Predictive factors and influence of intravesical therapy for recurrence of non-muscle invasive bladder cancer
    Garcia-Rodriguez, Jorge
    Fernandez Gomez, Jesus Maria
    Gonzalez Alvarez, Roberto Carlos
    Jalon Monzon, Antonio
    Regadera Sejas, Javier
    Martin Benito, Jose Luis
    SALUD I CIENCIA, 2009, 17 (03): : 247 - 251
  • [22] Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review
    Shelley, Mike D.
    Jones, Gabriel
    Cleves, Anne
    Wilt, Timothy J.
    Mason, Malcolm D.
    Kynaston, Howard G.
    BJU INTERNATIONAL, 2012, 109 (04) : 496 - 505
  • [23] Impact of intravesical therapy for non-muscle invasive bladder cancer on the accuracy of urine cytology
    Gupta, Mohit
    Milbar, Niv
    Tema, Giorgia
    Pederzoli, Filippo
    Chappidi, Meera
    Kates, Max
    VandenBussche, Christopher J.
    Bivalacqua, Trinity J.
    WORLD JOURNAL OF UROLOGY, 2019, 37 (10) : 2051 - 2058
  • [24] Impact of intravesical therapy for non-muscle invasive bladder cancer on the accuracy of urine cytology
    Mohit Gupta
    Niv Milbar
    Giorgia Tema
    Filippo Pederzoli
    Meera Chappidi
    Max Kates
    Christopher J. VandenBussche
    Trinity J. Bivalacqua
    World Journal of Urology, 2019, 37 : 2051 - 2058
  • [25] INTRAVESICAL GEMCITABINE FOR NON-MUSCLE INVASIVE BLADDER CANCER: A COCHRANE REVIEW
    Hwang, Eu Chang
    Maisch, Philipp
    Jung, Jae Hung
    Narayan, Vikram
    Cleves, Anne
    Dahm, Philipp
    JOURNAL OF UROLOGY, 2020, 203 : E1127 - E1127
  • [26] The Future of Intravesical Drug Delivery for Non-Muscle Invasive Bladder Cancer
    Douglass, Laura
    Schoenberg, Mark
    BLADDER CANCER, 2016, 2 (03) : 285 - 292
  • [27] Intravesical Admistration of Gemcitabine for the Treatment of non-muscle invasive Bladder Cancer
    Spek, Annabel
    UROLOGIE, 2022, 61 (06): : 653 - 656
  • [28] Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer
    Milbar, Niv
    Kates, Max
    Chappidi, Meera R.
    Pederzoli, Filippo
    Yoshida, Takahiro
    Sankin, Alexander
    Pierorazio, Phillip M.
    Schoenberg, Mark P.
    Bivalacqua, Trinity J.
    BLADDER CANCER, 2017, 3 (04) : 293 - 303
  • [29] IS INTRAVESICAL BCG ALONE STILL THE ONLY TRULY EFFECTIVE INTRAVESICAL THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER?
    Di Stasi, Savino Mauro
    Riedl, Claus
    Giannantoni, Antonella
    Verri, Cristian
    Celestino, Francesco
    De Carlo, Francesco
    Masedu, Francesco
    Valenti, Marco
    JOURNAL OF UROLOGY, 2015, 193 (04): : E381 - E381
  • [30] Early experience with sequential intravesical gemcitabine and docetaxel for micropapillary variant non-muscle invasive bladder cancer
    Chakra, Mohamad Abou
    Mcelree, Ian M.
    Packiam, Vignesh T.
    Mott, Sarah L.
    O'Donnell, Michael A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (09) : 289e13 - 289e21
12345